Leserbrief
A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer
Medicina Clínica · 2026-08 · 166 (8) · 107473
DOI: 10.1016/j.medcli.2026.107473 ↗Kurz gefasst
Leserbrief in der Zeitschrift Medicina Clínica, 2026-08. Verfasst von Nannan Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: zqzyzzh@163.com. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: zqzyzzh@163.com.
- Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: Miranda1246@163.com.
Zitieren
APA
Zhang, N., & Zou, Y. (2026). A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer. Medicina Clínica, 166(8), 107473. https://doi.org/10.1016/j.medcli.2026.107473
Vancouver
Zhang N, Zou Y. A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer. Medicina Clínica. 2026;166(8):107473. doi:10.1016/j.medcli.2026.107473
BibTeX
@article{Zhang2026,
author = {Zhang, Nannan and Zou, Yumeng},
title = {A case of thrombotic microangiopathy during tislelizumab therapy for lung cancer},
journal = {Medicina Clínica},
year = {2026},
volume = {166},
number = {8},
pages = {107473},
doi = {10.1016/j.medcli.2026.107473}
}
EUVIMED